Table 3.

Associations between Preoperative Characteristics of Study Participants and the Development of Postoperative Complications

	Total, N = 208	Did Not Develop Complications (n = 114)	Did Develop Complications (n = 64)	P
Age, average ± STD	7.6 ± 22.7	6.6 ± 21.3	8.9 ± 25.7	<0.001
Age ≤ 18	104 (50%)	84 (58%)	20 (31%)	<0.001
Age > 18	104 (50%)	60 (42%)	44 (69%)
BMI, average ± STD	24.8 ± 2.7	24.7 ± 2.8	24.9 ± 2.5	0.55
Hormone replacement therapy	93 (45%)	67 (46.5%)	26 (41%)	0.45
Tobacco smoking	57 (27%)	34 (24%)	23 (36%)	0.091
Hypertension	2 (1%)	2 (1%)	0	1.00
DM	8 (3.8%)	6 (4.2%)	2 (3.1%)	1.00
IBD	1 (0.5%)	1 (0.5%)	0
Hypothyroidism	9 (4.3%)	5 (3.5%)	4 (6.3%)	0.46
Psychiatric comorbidities	26 (12.5%)	20 (13.9%)	6 (9.4%)	0.49
Epilepsy	2 (1%)	2 (1%)	0	1.00
Asthma	14 (6.7%)	11 (7.6%)	3 (4.7%)	0.55
Migraines	1 (0.5%)	1 (0.5%)	0
Charlson comorbidity index	12 (5.8%)	7 (4.9%)	5 (7.8%)	0.52
Preoperative laboratory
Glucose	86.2 ± 10.0	86.5 ± 9.9	85.6 ± 10.4	0.55
HB	13.9 ± 4.5	13.9 ± 1.4	13.9 ± 1.7	0.94
PLT	265 [230–312]	264 [228–310]	269 [234–319]	0.59
Follow-up, d, average ± STD	1306 [653–2069]	1340 [658–1811]	1208 [644–3346]	0.33

Values in boldface indicate p < 0.05.